Apricus Wealth’s Colgate-Palmolive CL Stock Holding History

Apricus Wealth’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,145	Closed	-$201K	–	118
2025 Q1	$201K	Buy	+2,145	New	+$192K	0.12%	113
2024 Q4	–	Sell	-2,540	Closed	-$264K	–	102
2024 Q3	$264K	Buy	+2,540	New	+$259K	0.17%	81

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Broadwater Capital Boston, Massachusetts $134M AUM 21.11% 1-Year Est. Return

Apricus Wealth's CL Position: Q2 2025 in Review

Apricus Wealth sold out of Colgate-Palmolive (CL) in Q2 2025, closing a stake of 2,145 shares — an estimated $201K sold.

Apricus Wealth first reported a position in CL in Q3 2024 and held it in 2 quarters. The position peaked at $264K in Q3 2024. 1,913 funds tracked by Wall St. Rank hold CL as of Q2 2025.

Apricus Wealth reported no remaining Colgate-Palmolive position as of Q2 2025 after selling out during the quarter.
Apricus Wealth sold 2,145 Colgate-Palmolive shares in Q2 2025, an estimated $201K.
Apricus Wealth first reported a position in Colgate-Palmolive in Q3 2024 and held it in 2 quarters.
Apricus Wealth's Colgate-Palmolive position peaked at $264K in Q3 2024.
1,913 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2025.

Based on Apricus Wealth's 13F filing for Q2 2025, filed 30 Jul 2025.